LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | 0 | 7.01 | 17.25 | 967 | 389 | 2.4827 | 1.4482 | MN20160310_N02 | I18 | |
MCF 10A-H2B-mCherry | Etoposide | 10 | 7.01 | 17.25 | 1 | 389 | 0.0026 | -0.4692 | MN20160310_N02 | F18 |
MCF 10A-H2B-mCherry | Alpelisib | 0.01 | 7.01 | 17.25 | 1 | 389 | 0.0026 | -0.4692 | MN20160310_N02 | J15 |
MCF 10A-H2B-mCherry | Etoposide | 0.018333 | 7.01 | 17.25 | 883 | 389 | 2.2670 | 1.3993 | MN20160310_N02 | J08 |
MCF 10A-H2B-mCherry | 0 | 7.01 | 17.25 | 813 | 389 | 2.0873 | 1.3556 | MN20160310_N02 | K16 | |
MCF 10A-H2B-mCherry | Etoposide | 0.018333 | 7.01 | 17.25 | 17 | 389 | 0.0436 | -0.0033 | MN20160310_N02 | M07 |
MCF 10A-H2B-mCherry | 0 | 7.01 | 17.25 | 886 | 389 | 2.2747 | 1.4011 | MN20160310_N02 | M20 | |
MCF 10A-H2B-mCherry | Etoposide | 0.018333 | 7.01 | 17.25 | 968 | 389 | 2.4852 | 1.4488 | MN20160310_N02 | M07 |
MCF 10A-H2B-mCherry | 0 | 7.01 | 17.25 | 925 | 389 | 2.3748 | 1.4242 | MN20160310_N02 | L08 | |
MCF 10A-H2B-mCherry | Etoposide | 0.056667 | 7.01 | 17.25 | 843 | 389 | 2.1643 | 1.3746 | MN20160310_N02 | H04 |
MCF 10A-H2B-mCherry | Alpelisib | 0.1 | 7.01 | 17.25 | 713 | 389 | 1.8306 | 1.2878 | MN20160310_N02 | E10 |
MCF 10A-H2B-mCherry | Dasatinib | 10 | 7.01 | 17.25 | 808 | 389 | 2.0745 | 1.3524 | MN20160310_N02 | N03 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 7.01 | 17.25 | 1 | 389 | 0.0026 | -0.4692 | MN20160310_N02 | L17 |
MCF 10A-H2B-mCherry | Etoposide | 0.056667 | 7.01 | 17.25 | 12 | 389 | 0.0308 | -0.0776 | MN20160310_N02 | H04 |
MCF 10A-H2B-mCherry | Alpelisib | 5.6234 | 7.01 | 17.25 | 927 | 389 | 2.3800 | 1.4253 | MN20160310_N02 | J07 |
MCF 10A-H2B-mCherry | Etoposide | 0.056667 | 7.01 | 17.25 | 824 | 389 | 2.1155 | 1.3626 | MN20160310_N02 | F14 |
MCF 10A-H2B-mCherry | Alpelisib | 5.6234 | 7.01 | 17.25 | 1 | 389 | 0.0026 | -0.4692 | MN20160310_N02 | J07 |
MCF 10A-H2B-mCherry | Etoposide | 10 | 7.01 | 17.25 | 1 | 389 | 0.0026 | -0.4692 | MN20160310_N02 | L13 |
MCF 10A-H2B-mCherry | Alpelisib | 0.0033333 | 7.01 | 17.25 | 21 | 389 | 0.0539 | 0.0447 | MN20160310_N02 | M22 |
MCF 10A-H2B-mCherry | Etoposide | 0.17783 | 7.01 | 17.25 | 949 | 389 | 2.4365 | 1.4380 | MN20160310_N02 | J21 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 7.01 | 17.25 | 920 | 389 | 2.3620 | 1.4213 | MN20160310_N02 | L17 |
MCF 10A-H2B-mCherry | Etoposide | 10 | 7.01 | 17.25 | 590 | 389 | 1.5148 | 1.1935 | MN20160310_N02 | L13 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 7.01 | 17.25 | 1 | 389 | 0.0026 | -0.4692 | MN20160310_N02 | N15 |
MCF 10A-H2B-mCherry | Etoposide | 0.17783 | 7.01 | 17.25 | 1 | 389 | 0.0026 | -0.4692 | MN20160310_N02 | J21 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 7.01 | 17.25 | 966 | 389 | 2.4801 | 1.4477 | MN20160310_N02 | N15 |